EUVIMEDEUVIMED entdecken
Crossref

A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma

Zhou Tian iD, Qitao Hu, Zhouyi Sun, Ning Wang, Huiling He, Zhe Tang, Weiyu Chen iD

ACS Nano · 2023

DOI: 10.1021/acsnano.3c08064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Zhou Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy, Radiofrequency Ablation. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Primary Research and Development Plan of Zhejiang Province, National Natural Science Foundation of China, Jinhua Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsImmunotherapyRadiofrequency AblationCancer VaccinesB7-H1 AntigenNanoparticlesAnimalsMiceHumansCell Line, TumorDendritic CellsMice, Inbred C57BLNanovaccines

Stichwörter der Autor:innen

ImmunotherapyIn situ therapeutic vaccineLayered double hydroxidesPD-L1Radiofrequency ablation

Substanzen

Cancer VaccinesB7-H1 AntigenNanovaccines

Autor:innen und Institutionen

  • Department of General Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
  • Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, China.
  • Department of Ultrasonography, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
  • Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, HangZhou, Zhejiang 310000, China.
  • Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
  • International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.

ORCID-Profile: Zhou Tian, Weiyu Chen

Förderung

  • Primary Research and Development Plan of Zhejiang Province
  • National Natural Science Foundation of China
  • Jinhua Science and Technology Bureau
  • Natural Science Foundation of Zhejiang Province
  • Huadong Medicine

Zitieren

APA

Tian, Z., Hu, Q., Sun, Z., Wang, N., He, H., Tang, Z., & Chen, W. (2023). A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma. ACS Nano. https://doi.org/10.1021/acsnano.3c08064

Vancouver

Tian Z, Hu Q, Sun Z, Wang N, He H, Tang Z, et al. A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma. ACS Nano. 2023. doi:10.1021/acsnano.3c08064

BibTeX
@article{Tian2023,
  author = {Tian, Zhou and Hu, Qitao and Sun, Zhouyi and Wang, Ning and He, Huiling and Tang, Zhe and Chen, Weiyu},
  title = {A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma},
  journal = {ACS Nano},
  year = {2023},
  doi = {10.1021/acsnano.3c08064}
}
Kostenlos starten →